miércoles, 2 de septiembre de 2020

Congressional committee to subpoena AbbVie in drug pricing investigation

Congressional committee to subpoena AbbVie in drug pricing investigation

Daily Recap

STAT Plus: Congressional committee to subpoena AbbVie in drug pricing investigation

By ED SILVERMAN


RUBY WALLAU FOR STAT
"AbbVie has demonstrated its unwillingness to comply voluntarily with the Committee’s investigation,” wrote committee chair Carolyn Maloney.

No hay comentarios: